3SBio (SSRX) Tops Q4 EPS by 2c; Guides FY12 Revs

3SBio (NASDAQ: SSRX) reported Q4 EPS of $0.16, $0.02 better than the analyst estimate of $0.14. Revenue for the quarter came in at $22.2 million versus the consensus estimate of $20.45 million.

Sees FY2012 revenue of $99-$108 million, versus the consensus of $102.7 million.

For earnings history and earnings-related data on 3SBio (SSRX) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• CorMedix (CRMD) Tops Q2 EPS by 6c; Offers Guidance
• Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation